EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines

Veronica Ghini iD, Flavia Sorbi iD, Massimiliano Fambrini, Francesca Magherini iD

Cells · 2024

DOI: 10.3390/cells13080661 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cells, 2024. Verfasst von Veronica Ghini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "Ugo Schiff", University of Florence, 50019 Sesto Fiorentino, Italy. Hauptthemen laut MEDLINE: Cisplatin, Ovarian Neoplasms, Metabolomics, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cell lines are frequently used in metabolomics, such as in vitro tumor models. In particular, A2780 cells are commonly used as a model for ovarian cancer to evaluate the effects of drug treatment. Here, we compare the NMR metabolomics profiles of A2780 and cisplatin-resistant A2780 cells with those of cells derived from 10 patients with high-grade serous ovarian carcinoma (collected during primary cytoreduction before any chemotherapeutic treatment). Our analysis reveals a substantial similarity among all primary cells but significant differences between them and both A2780 and cisplatin-resistant A2780 cells. Notably, the patient-derived cells are closer to the resistant A2780 cells when considering the exo-metabolome, whereas they are essentially equidistant from A2780 and A2780-resistant cells in terms of the endo-metabolome. This behavior results from dissimilarities in the levels of several metabolites attributable to the differential modulation of underlying biochemical pathways. The patient-derived cells are those with the most pronounced glycolytic phenotype, whereas A2780-resistant cells mainly diverge from the others due to alterations in a few specific metabolites already known as markers of resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinOvarian NeoplasmsMetabolomicsDrug Resistance, NeoplasmMagnetic Resonance SpectroscopyHumansFemaleCell Line, TumorMetabolomeAntineoplastic Agents

Stichwörter der Autor:innen

NMRcell linesmetabolomicsovarian cancerprimary cells

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry "Ugo Schiff", University of Florence, 50019 Sesto Fiorentino, Italy.
  • Magnetic Resonance Center (CERM), University of Florence, 50019 Sesto Fiorentino, Italy.
  • Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.

ORCID-Profile: Veronica Ghini, Flavia Sorbi, Francesca Magherini

Zitieren

APA

Ghini, V., Sorbi, F., Fambrini, M., & Magherini, F. (2024). NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines. Cells. https://doi.org/10.3390/cells13080661

Vancouver

Ghini V, Sorbi F, Fambrini M, Magherini F. NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines. Cells. 2024. doi:10.3390/cells13080661

BibTeX
@article{Ghini2024,
  author = {Ghini, Veronica and Sorbi, Flavia and Fambrini, Massimiliano and Magherini, Francesca},
  title = {NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13080661}
}
Kostenlos starten →